BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 490 | Download: 1791
 |
Received |
|
2023-03-27 14:58 |
|
Peer-Review Started |
|
2023-03-27 15:01 |
|
First Decision by Editorial Office Director |
|
2023-05-18 10:49 |
|
Return for Revision |
|
2023-05-18 10:49 |
|
Revised |
|
2023-06-04 14:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-29 02:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-03 15:09 |
|
Articles in Press |
|
2023-07-03 15:09 |
|
Edit the Manuscript by Language Editor |
|
2023-06-19 17:35 |
|
Typeset the Manuscript |
|
2023-07-10 02:03 |
|
Publish the Manuscript Online |
|
2023-07-13 08:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Martina Crepaldi, Daria Maniero, Alessandro Massano, Margherita Pavanato, Brigida Barberio, Edoardo Vincenzo Savarino and Fabiana Zingone |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabiana Zingone, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2
, Padua 35128, Italy. fabiana.zingone@unipd.it |
| Key Words |
Azathioprine; Inflammatory bowel diseases; Ulcerative Colitis; Crohn's Disease; Relapse; Side effects |
| Core Tip |
Prolonged use of azathioprine (AZA) remains controversial, and the time of interruption is uncertain. This retrospective study analyzed our single-center data of patients affected by inflammatory bowel disease who had started and then discontinued AZA between 1995 and 2022. AZA administration was effective and safe, and only 10% of patients who achieved remission with AZA needed a new treatment within 1 year of drug interruption. |
| Publish Date |
2023-07-13 08:46 |
| Citation |
Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i27.4334 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
